Cyclobenzaprine Hydrochloride
Product Images NDC 10544-072

2 FDA label images from Blenheim Pharmacal, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Cyclobenzaprine Hydrochloride (NDC 10544-072). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Blenheim Pharmacal, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Cyclobenzaprine HCL)

Chemical Structure (Cyclobenzaprine HCL)
Chemical structure diagram of cyclobenzaprine hydrochloride showing its molecular framework including benzene rings and nitrogen-containing side chain, with an associated HCl molecule.*
FDA Label Image

Label Graphic-cyclobenzaprine 10mg 15s (3d3179d3 E2f0 4d4f Aef6 Dc18b26fd4a7 02)

Label Graphic-cyclobenzaprine 10mg 15s (3d3179d3 E2f0 4d4f Aef6 Dc18b26fd4a7 02)
Cyclobenzaprine Hydrochloride Tablets, USP 10 mg, packaged by Blenheim Pharmacal, Inc. The label shows a bottle containing 15 tablets, with dosage instructions to see the package insert. Storage instructions indicate keeping the product in a controlled room temperature of 20°-25°C (68°-77°F) in a light-resistant container, out of reach of children. The NDC on the label is 10544-072-15.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.